| PBCJX | RGEBX | PBCJX / RGEBX | |
| Total Expense Ratio | 0.77 | 1.09 | 71% |
| Annual Report Gross Expense Ratio | 0.80 | 1.09 | 73% |
| Fund Existence | 8 years | 11 years | - |
| Gain YTD | 6.708 | 15.314 | 44% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 10.4B | 327B | 3% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 1.90 | 6.15 | 31% |
| Returns for 3 years | 67.05 | 60.18 | 111% |
| Returns for 5 years | 41.78 | 30.81 | 136% |
| Returns for 10 years | N/A | 81.54 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ASMH | 71.54 | 2.48 | +3.59% |
| ASML HOLDING NV ADRHEDGED ASMH | |||
| FTXO | 34.28 | 0.34 | +1.01% |
| First Trust Nasdaq Bank ETF | |||
| BUFX | 20.82 | 0.01 | +0.03% |
| FT Vest Laddered Enh & Mod Buffer ETF | |||
| TAFI | 25.25 | -0.01 | -0.04% |
| AB Tax-Aware Short Duration ETF | |||
| IBBQ | 27.71 | -0.27 | -0.95% |
| Invesco Nasdaq Biotechnology ETF | |||